Correction: model‑based alternative dosing strategies for subcutaneous nivolumab to improve cost effectiveness

Author(s):: Wang, Y.; Bukkems, L.H.; Heine, R. ter; Hasselt, J.G.C. van (0000-0002-1664-7314); Koolen, S.L.W.; Hendikx J.J.M.A.; Hulle, T. van der; Kapiteijn, E.; Zwaveling, J.; Becker, A.; Heuvel, M.M. van den; Theelen, W.S.M.E.; Oude Munnink, T.H.; Smit, E.F.; Guchelaar, H.J.; Moes, D.J.A.R.

Published: 2026
Publication type: Article / Letter to editor

Date issued: 2026-03-12
Language: English
Publisher: Springer Science and Business Media LLC
Is part of: Clinical Pharmacokinetics (2026), Vol. 65, p. 633-633
hdl: 1887/4307176
doi: 10.1007/s40262-026-01627-3
URL: https://doi.org/10.1007/s40262-026-01627-3